CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
low power laserother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02453113
NCT02453113N/ACompleted
CompareCT.gov

Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment

University of California, Irvine·interventional·Posted May 25, 2015·Updated Nov 1, 2022

In Brief

A clinical study evaluating low power laser for Vaccine Response Impaired. Completed, enrolled 10 participants across 2 sites.

Detailed Summary

The purpose of this is that the researcher can use low power Near Infrared laser treatment non-painful and non-damaging dose to changes the skin properties.The researcher can prove that signaling and a significant increase in the number of skin cells in skin tissue exposed to the laser can improve the human skin immune system to help improve human body response to vaccines.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVaccine Response Impaired
CountriesUnited States
CollaboratorsMassachusetts General Hospital, Beckman Laser Institute University of California Irvine

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 25, 2015
Enrollment StartJun 1, 2015
Primary CompletionJan 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 11.1 years ago

Interventions

low power laserother

Signaling in Human Skin Associated with Low-Power, Infrared Laser Treatment